<DOC>
	<DOCNO>NCT02516826</DOCNO>
	<brief_summary>1 . Stains demonstrate consistent benefit reduce cardiovascular event several primary secondary prevention trial . The suppression plaque progression regression may part mechanism clinical benefit . The intravascular ultrasound study demonstrate intensive statin therapy regress inhibit progression coronary atherosclerosis . 2 . Unregulated renin-angiotensin system important pathogenesis cardiovascular disease . Angiotensin receptor antagonist ( ARB ) report improve clinical outcome patient heart failure , leave ventricular dysfunction , myocardial infarction , high-risk patient . Several small study show ARBs effective inhibit progression coronary atherosclerosis intravascular ultrasound examination . 3 . The combined therapy statin ARBs may additive synergistic effect atherosclerosis regression well improve endothelial dysfunction insulin resistance addition lower cholesterol level blood pressure compare either monotherapy patient . 4 . Serial compute tomography angiography ( CTA ) utilize assess effect treatment coronary plaque morphology . In addition assessment luminal stenosis , CTA also allow characterization plaque morphology .</brief_summary>
	<brief_title>The Effect Rosuvastatin Olmesartan Progression Coronary Atherosclerotic Disease</brief_title>
	<detailed_description />
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Subjects must 19 years~70 year age 2 . Patients undergo coronary CTA coronary artery stenosis 30~70 % 3 . Informed consent 4 . Appropriate CT resolution enough measure plaque volume 5 . Patients stain reninangiotensin system blocker na√Øve least 1 year 1 . Patients &gt; =70 % luminal stenosis require percutaneous coronary intervention ( PCI ) 2 . Severely calcifiedcoronary artery 3 . Patients history previous PCI coronary artery bypass graft surgery .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>